Therapeutic method for activating factor VII
US4456591A · kind A · utility
32Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 29, 1982 |
| Grant date | Jun 26, 1984 |
| Priority date | — |
| Expiry date | Nov 29, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/4846
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Patients having a clotting factor defect can be successfully treated by the administration of a composition containing effective hemostatic amounts of factor VIIa. Preferably, the factor VIIa is substantially free of factors IXa and Xa. Procedures for preparing the above therapeutic compositions are also described. A method involving the activation of factor VII is set forth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.